Understanding the pharmacology and physiology of RAS antagonists is essential for managing the hemodynamic risks, such as unexpected hypotension, in patients undergoing anesthesia.
Answers are grounded in this paper and cite their sources.
Clinicians should anticipate hypotension with RAS blockade during anesthesia; this review leaves open optimal perioperative strategies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ryckwaert et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: